NeoGenomics Sees Q3 Revenue Of About $209M; Reiterates FY2026 Revenue, Adjusted EBITDA Guidance, Expects To Raise Revenue Guidance Midpoint On Q3 Call

NeoGenomics expects 3Q revenue of about $209 million, with next-generation sequencing revenue up roughly 28% year over year. The company says the preliminary figure is expected to lead to an increase in full-year revenue guidance at the midpoint, with details to come on the earnings call. The compa…